Danaher's proposed acquisition of GE BioPharma has been cleared in South Korea, conditional on a divestment package.
The Korea Fair Trade Commission has granted approval to Danaher's $21.4 billion acquisition of the biopharma unit of GE Healthcare's Life Sciences, an affiliate of General Electric, on condition that eight of the
* = Required Field
*Areas of Interest
MLex content is primarily organized into seven Areas of Interest that cover the main elements of regulatory risk.
Please indicate which ones you would like to be included in your Daily Wrap-up alert